Expression of nitric oxide synthase in pleomorphic adenomas of the parotid

P A Brennan1, T Umar, J Buckley

  • 1Oral and Maxillofacial Surgery, Queen Alexandra Hospital, Portsmouth, UK.

Insights

Inducible nitric oxide synthase (iNOS) expression significantly increased in parotid pleomorphic adenomas compared to normal tissue. Endothelial nitric oxide synthase (eNOS) showed minimal changes, suggesting iNOS plays a role in these salivary gland tumors.

Area of Science:

  • Oncology
  • Pathology
  • Biochemistry

Background:

  • Nitric oxide (NO) has complex roles in solid tumors, exhibiting both inhibitory and tumor-promoting activities.
  • Understanding the specific roles of different nitric oxide synthase (NOS) isoforms is crucial for elucidating tumor pathology.

Purpose of the Study:

  • To investigate immunohistochemically the expression of inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) in pleomorphic adenomas of the parotid.
  • To compare the expression patterns of iNOS and eNOS in tumor tissue versus normal salivary gland tissue.

Main Methods:

  • Immunohistochemistry was employed to detect and quantify iNOS and eNOS expression.
  • The study analyzed 30 cases of parotid pleomorphic adenomas and compared them with normal salivary tissue.

Main Results:

  • A significant difference in iNOS staining was observed between tumor and normal tissues (P<0.0001).
  • Tumor epithelial cells showed iNOS staining in 29 out of 30 cases, with positive staining also noted in salivary ductal luminal cells.
  • eNOS staining was minimal in tumor epithelium and salivary duct cells, with mild staining observed in blood vessel endothelium in both tumor and normal tissues.

Conclusions:

  • The study indicates a significant upregulation of iNOS in parotid pleomorphic adenomas.
  • The findings suggest that iNOS, but not eNOS, is differentially expressed in these tumors, potentially contributing to their pathology.